These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat. Hoskin KL; Goadsby PJ Exp Neurol; 1998 Mar; 150(1):45-51. PubMed ID: 9514827 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of low dose CP122,288 and eletriptan on fos expression due to stimulation of the superior sagittal sinus in cat. Goadsby PJ; Hoskin KL Pain; 1999 Jul; 82(1):15-22. PubMed ID: 10422655 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine? Goadsby PJ; Hoskin KL Pain; 1996 Oct; 67(2-3):355-9. PubMed ID: 8951929 [TBL] [Abstract][Full Text] [Related]
6. Substance P blockade with the potent and centrally acting antagonist GR205171 does not effect central trigeminal activity with superior sagittal sinus stimulation. Goadsby PJ; Hoskin KL; Knight YE Neuroscience; 1998 Sep; 86(1):337-43. PubMed ID: 9692766 [TBL] [Abstract][Full Text] [Related]
7. Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study. Hoskin KL; Kaube H; Goadsby PJ Brain; 1996 Feb; 119 ( Pt 1)():249-56. PubMed ID: 8624686 [TBL] [Abstract][Full Text] [Related]
8. Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. Moskowitz MA; Nozaki K; Kraig RP J Neurosci; 1993 Mar; 13(3):1167-77. PubMed ID: 8382735 [TBL] [Abstract][Full Text] [Related]
9. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288. Knight YE; Edvinsson L; Goadsby PJ Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470 [TBL] [Abstract][Full Text] [Related]
10. Effect of a serotonin agonist (sumatriptan) on the peptidergic innervation of the rat cerebral dura mater and on the expression of c-fos in the caudal trigeminal nucleus in an experimental migraine model. Knyihár-Csillik E; Tajti J; Samsam M; Sáry G; Slezák S; Vécsei L J Neurosci Res; 1997 Jun; 48(5):449-64. PubMed ID: 9185668 [TBL] [Abstract][Full Text] [Related]
11. The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: a c-fos immunocytochemical study. Goadsby PJ; Hoskin KL J Anat; 1997 Apr; 190 ( Pt 3)(Pt 3):367-75. PubMed ID: 9147223 [TBL] [Abstract][Full Text] [Related]
12. CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges. Nozaki K; Moskowitz MA; Boccalini P Br J Pharmacol; 1992 Jun; 106(2):409-15. PubMed ID: 1327382 [TBL] [Abstract][Full Text] [Related]
13. Suppression by the sumatriptan analogue, CP-122,288 of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin. Cutrer FM; Schoenfeld D; Limmroth V; Panahian N; Moskowitz MA Br J Pharmacol; 1995 Mar; 114(5):987-92. PubMed ID: 7780655 [TBL] [Abstract][Full Text] [Related]
14. Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat. Kaube H; Keay KA; Hoskin KL; Bandler R; Goadsby PJ Brain Res; 1993 Nov; 629(1):95-102. PubMed ID: 8287282 [TBL] [Abstract][Full Text] [Related]
15. Stimulation of the middle meningeal artery leads to Fos expression in the trigeminocervical nucleus: a comparative study of monkey and cat. Hoskin KL; Zagami AS; Goadsby PJ J Anat; 1999 May; 194 ( Pt 4)(Pt 4):579-88. PubMed ID: 10445825 [TBL] [Abstract][Full Text] [Related]
16. Distribution of fos-like immunoreactivity in the medullary and upper cervical dorsal horn produced by stimulation of dural blood vessels in the rat. Strassman AM; Mineta Y; Vos BP J Neurosci; 1994 Jun; 14(6):3725-35. PubMed ID: 8207485 [TBL] [Abstract][Full Text] [Related]
17. The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity within the trigeminocervical complex following superior sagittal sinus stimulation in the cat. Classey JD; Knight YE; Goadsby PJ Brain Res; 2001 Jul; 907(1-2):117-24. PubMed ID: 11430892 [TBL] [Abstract][Full Text] [Related]
18. Headache: classification, mechanism and principles of therapy, with particular reference to migraine. Lance JW Recenti Prog Med; 1989 Dec; 80(12):673-80. PubMed ID: 2516913 [TBL] [Abstract][Full Text] [Related]
19. Increased susceptibility to cortical spreading depression in an animal model of medication-overuse headache. Green AL; Gu P; De Felice M; Dodick D; Ossipov MH; Porreca F Cephalalgia; 2014 Jul; 34(8):594-604. PubMed ID: 24335852 [TBL] [Abstract][Full Text] [Related]
20. Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine. Martin GR Cephalalgia; 1997 Oct; 17 Suppl 18():4-14. PubMed ID: 9399012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]